A phase 2 trial of mini‐hyper‐<scp>CVD</scp>, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/10.1002/ajh.27463

Keywords:

Abstract:

Source: